Vident Investment Advisory’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,521
Closed -$205K 1183
2021
Q2
$205K Buy
+8,521
New +$205K 0.01% 1050